12
Participants
Start Date
April 13, 2023
Primary Completion Date
July 10, 2023
Study Completion Date
July 10, 2023
PF-07817883
Single oral dose (period 1) or co-administered with itraconazole (period 2)
Itraconazole
Interacting drug which will be given for 7 days in period 2
New Haven Clinical Research Unit, New Haven
Lead Sponsor
Pfizer
INDUSTRY